๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients

โœ Scribed by Seif, Alix E.; Walker, Dana M.; Li, Yimei; Huang, Yuan-Shung V.; Kavcic, Marko; Torp, Kari; Bagatell, Rochelle; Fisher, Brian T.; Aplenc, Richard

Book ID
126559799
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
237 KB
Volume
62
Category
Article
ISSN
1545-5009

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Telomerase activity is prognostic in ped
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia : Comparison with adult acute myeloid leukemia
โœ Srdan Verstovsek; Taghi Manshouri; Franklin O. Smith; Francis J. Giles; Jorge Co ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Significantly elevated telomerase activity (TA) has been found in samples from patients with almost all malignant hematologic diseases. The impact of elevated TA on the course of pediatric patients with acute myeloid leukemia (Pโ€AML) is unknown. ## METHODS Using a modif

RAS gene mutations in childhood acute my
RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study
โœ Dr. Bert Vogelstein; Dr. Curt I. Civin; Antonette C. Preisinger; Jeffrey P. Kris ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 336 KB

Mutations at codon I 2, I 3, and 6 I of the HRAS, KRAS, and NRASgenes were evaluated in 99 cases of pediatric acute myeloid leukemia (AML) using oligonucleotide hybridization to polymerase chain reacted derived products. Twenty-four mutations were identified in the NRAS gene, I 3 in the KRAS gene, a